AmountSee official notice
Deadline2027-10-15
LocationUnited States
Who May QualifyReview the official notice for eligible applicant types.
IndustryVaries by opportunity
What It FundsEarly Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
About This Grant
Current federal funding opportunity PAR-25-184. Review the official notice for the complete scope, award information, eligibility and application instructions.
Verify With the Funder
The official federal details page can be viewed without signing in. Grants.gov sign in is only required when you are ready to submit or manage an application.
Last verified: 9/5/2026
Source: View the official source